Oculis Holding AG (OCS) Depreciation & Amortization - Total (2023 - 2026)

Oculis Holding AG (OCS) recorded quarterly Depreciation & Amortization - Total of $196658.7 in Q1 2026, down 0.52% quarter-over-quarter from $197684.8 in Q4 2025, and up 43.75% on a YoY basis from $136806.8 in Q1 2025.

Oculis Holding AG (OCS) Depreciation & Amortization - Total (2023 - 2026) Analysis & Trends

Oculis Holding AG's Depreciation & Amortization - Total history runs 4 years deep, the most recent figure standing at $196658.7 for Q1 2026.

  • In Q1 2026, Depreciation & Amortization - Total rose 43.75% year-over-year to $196658.7; the TTM figure through Mar 2026 stood at $720851.8 (up 39.89% YoY), while the FY2025 annual figure was $683138.7, up 47.4% from the prior year.
  • Depreciation & Amortization - Total was $196658.7 for Q1 2026 at Oculis Holding AG, down from $197684.8 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $197684.8 in Q4 2025 to a low of $82647.1 in Q3 2023.
  • Historically, Depreciation & Amortization - Total has averaged $135078.1 across 4 years, with a median of $136806.8 in 2025.
  • The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization - Total soared 70.38% in 2024, then jumped 34.94% in 2025.
  • A 4-year view of Depreciation & Amortization - Total shows it stood at $83424.2 in 2023, then soared by 66.94% to $139265.7 in 2024, then soared by 41.95% to $197684.8 in 2025, then retreated by 0.52% to $196658.7 in 2026.
  • The last three Depreciation & Amortization - Total figures came in at $196658.7 (Q1 2026), $197684.8 (Q4 2025), and $190016.6 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 196,658.72

Historic Data

Download Data
DateValue
Mar 31, 2026 196,658.72
Dec 31, 2025 197,684.83
Sep 30, 2025 190,016.65
Jun 30, 2025 136,491.60
Mar 31, 2025 136,806.82
Dec 31, 2024 139,265.67
Sep 30, 2024 140,813.28
Jun 30, 2024 98,415.62
Mar 31, 2024 83,634.81
Dec 31, 2023 83,424.23
Sep 30, 2023 82,647.14